This Old Drug Was Free. Now It's $109,500 a Year

The zigzagging trajectory of the price of Daranide, now known as Keveyis, shows just how much freedom drug companies have in pricing therapies — and what a big business opportunity selling rare-disease drugs has become.

Read Full Article »

Show comments Hide Comments

Related Articles

Market Overview
Search Stock Quotes